Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
65.11B
Market cap65.11B
Price-Earnings ratio
42.16
Price-Earnings ratio42.16
Dividend yield
0.67%
Dividend yield0.67%
Average volume
938.61K
Average volume938.61K
High today
$339.47
High today$339.47
Low today
$333.79
Low today$333.79
Open price
$335.47
Open price$335.47
Volume
917.91K
Volume917.91K
52 Week high
$377.54
52 Week high$377.54
52 Week low
$233.61
52 Week low$233.61

Stock Snapshot

The current Cencora, Inc.(COR) stock price is $335.69, with a market capitalization of 65.11B. The stock trades at a price-to-earnings (P/E) ratio of 42.16 and offers a dividend yield of 67.0%.

During the trading session on 2026-01-12, Cencora, Inc.(COR) shares reached a daily high of $339.47 and a low of $333.79. At a current price of $335.69, the stock is +0.6% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 917.91K, compared to an average daily volume of 938.61K.

The stock's 52-week range extends from a low of $233.61 to a high of $377.54.

The stock's 52-week range extends from a low of $233.61 to a high of $377.54.

COR News

Simply Wall St 3d
Is It Too Late To Consider Cencora After A 236% Five Year Run?

If you are wondering whether Cencora’s share price still offers value after a strong run, this article walks through what the numbers actually say about the sto...

Is It Too Late To Consider Cencora After A 236% Five Year Run?
Nasdaq 4d
Here's Why You Should Retain Cencora Stock in Your Portfolio Now

Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, intense competition is a c...

Here's Why You Should Retain Cencora Stock in Your Portfolio Now
Simply Wall St 6d
Assessing Cencora Valuation After Strong Multi Year Total Returns

Advertisement Cencora’s recent performance in focus Cencora (COR) has drawn investor attention after a stretch of strong multi year total returns and fresh ga...

Assessing Cencora Valuation After Strong Multi Year Total Returns

Analyst ratings

70%

of 20 ratings
Buy
70%
Hold
30%
Sell
0%

More COR News

TipRanks 7d
Cencora price target lowered to $360 from $380 at BofA

BofA lowered the firm’s price target on Cencora (COR) to $360 from $380 and keeps a Neutral rating on the shares. Heading into 2026, the firm maintains its posi...

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.